DLC1 and Liver Cancer: The Akt Connection

被引：3
|
作者：
Wuestefeld, Torsten
Zender, Lars [1 ]
机构：
[1] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany
来源：
GASTROENTEROLOGY | 2010年 / 139卷 / 04期
关键词：
HUMAN HEPATOCELLULAR-CARCINOMA; GTPASE-ACTIVATING PROTEIN; SUPPRESSOR GENE DLC1; TUMOR-SUPPRESSOR; ABERRANT METHYLATION; PROSTATE-CANCER; CELL; 8P22; EXPRESSION; PROGNOSIS;
D O I：
10.1053/j.gastro.2010.08.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1093 / 1096
页数：5
相关论文
共 50 条
  • [31] Sequence variants of DLC1 in colorectal and ovarian tumours
    Wilson, PJ
    McGlinn, E
    Marsh, A
    Evans, T
    Arnold, J
    Wright, K
    Biden, K
    Young, J
    Wainwright, B
    Wicking, C
    Chenevix-Trench, G
    HUMAN MUTATION, 2000, 15 (02) : 156 - 165
  • [32] Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer
    Singh, Deepika
    Bharti, Amisha
    Biswas, Dipanjan
    Tewari, Mallika
    Kar, Amrita Ghosh
    Ansari, Mumtaz Ahmed
    Singh, Sunita
    Narayan, Gopeshwar
    JOURNAL OF GASTROINTESTINAL CANCER, 2022, 53 (02) : 237 - 244
  • [33] A tumor suppressor DLC1: The functions and signal pathways
    Zhang, Yang
    Li, Guorong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (06) : 4999 - 5007
  • [34] Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study
    Zheng, SQL
    Mychaleckyj, JC
    Hawkins, GA
    Isaacs, SD
    Wiley, KE
    Turner, A
    Chang, BL
    von Kap-Herr, C
    Carpten, JD
    Pettenati, M
    Bleecker, ER
    Walsh, PC
    Trent, JM
    Meyers, DA
    Isaacs, WB
    Xu, JF
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 528 (1-2) : 45 - 53
  • [35] Epigenetic reactivation of the DLC1 tumor suppressor protein is a new approach for cancer treatment
    Tripathi, Brajendra K.
    Boccuzzi, Luciarita
    Anderman, Meghan
    Qian, Xiaolan
    Walters, Kylie J.
    Doroshow, James H.
    Lowy, Douglas R.
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Cooperation of DLC1 and CDK6 Affects Breast Cancer Clinical Outcome
    Dai, Xiaofeng
    Li, Lu
    Liu, Xiuxia
    Hu, Weiguo
    Yang, Yankun
    Bai, Zhonghu
    G3-GENES GENOMES GENETICS, 2015, 5 (01): : 81 - 91
  • [37] Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer
    Deepika Singh
    Amisha Bharti
    Dipanjan Biswas
    Mallika Tewari
    Amrita Ghosh Kar
    Mumtaz Ahmed Ansari
    Sunita Singh
    Gopeshwar Narayan
    Journal of Gastrointestinal Cancer, 2022, 53 : 237 - 244
  • [38] GAP-independent functions of DLC1 in metastasis
    Barras, David
    Widmann, Christian
    CANCER AND METASTASIS REVIEWS, 2014, 33 (01) : 87 - 100
  • [39] The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma
    Wu, Hui-Ta
    Xie, Cheng-Rong
    Lv, Jie
    Qi, He-Qiang
    Wang, Fei
    Zhang, Sheng
    Fang, Qin-Liang
    Wang, Fu-Qiang
    Lu, Yu-Yan
    Yin, Zhen-Yu
    LABORATORY INVESTIGATION, 2018, 98 (08) : 1014 - 1024
  • [40] High expression of GAPDH is relevant to lung adenocarcinoma with low expression of the tumor suppressor gene Deleted in Liver Cancer-1 (DLC1)
    Wang, Dunrui
    Zhang, Guangxian
    CANCER RESEARCH, 2014, 74 (19)
12345